Clinical Trial Update: A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/Phase 2 methodology development environmental study of reproxalap in subjects with seasonal allergic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Seasonal Allergic Conjunctivitis

Drugs mentioned

• Reproxalap (reproxalap)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Allergic Conjunctivitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-08